ID: ALA2313334

Max Phase: Preclinical

Molecular Formula: C36H41N7O11

Molecular Weight: 747.76

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [N-]=[N+]=NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)nn3)[C@H]2O)[C@H](O)[C@H]1NC(=O)c1ccccc1

Standard InChI:  InChI=1S/C36H41N7O11/c37-41-38-16-7-17-50-35-28(39-34(49)22-8-3-1-4-9-22)31(47)33(27(20-45)53-35)54-36-32(48)29(30(46)26(19-44)52-36)43-18-25(40-42-43)21-12-14-24(15-13-21)51-23-10-5-2-6-11-23/h1-6,8-15,18,26-33,35-36,44-48H,7,16-17,19-20H2,(H,39,49)/t26-,27-,28-,29+,30+,31-,32-,33-,35-,36+/m1/s1

Standard InChI Key:  CMMAHYMRBBHCBK-MZTZKZOHSA-N

Associated Targets(Human)

Galectin-3 545 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-1 387 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 747.76Molecular Weight (Monoisotopic): 747.2864AlogP: 1.70#Rotatable Bonds: 15
Polar Surface Area: 255.87Molecular Species: ACIDHBA: 15HBD: 6
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: -10.56CX Basic pKa: CX LogP: 1.77CX LogD: 1.65
Aromatic Rings: 4Heavy Atoms: 54QED Weighted: 0.04Np Likeness Score: 0.18

References

1. van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ..  (2013)  Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.,  56  (3): [PMID:23281927] [10.1021/jm301677r]

Source